Singapore markets open in 2 hours 23 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.71+1.91 (+7.70%)
At close: 04:00PM EDT
26.00 -0.71 (-2.66%)
After hours: 05:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.10B
Enterprise value 613.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.55k
Price/book (mrq)2.92
Enterprise value/revenue 1.68k
Enterprise value/EBITDA -3.05

Trading information

Stock price history

Beta (5Y monthly) -0.26
52-week change 3-62.83%
S&P500 52-week change 3-4.45%
52-week high 383.60
52-week low 312.67
50-day moving average 318.43
200-day moving average 324.86

Share statistics

Avg vol (3-month) 3254.69k
Avg vol (10-day) 3257.39k
Shares outstanding 528.97M
Implied shares outstanding 6N/A
Float 811.29M
% held by insiders 138.75%
% held by institutions 164.74%
Shares short (28 Jul 2022) 43.32M
Short ratio (28 Jul 2022) 423.36
Short % of float (28 Jul 2022) 428.89%
Short % of shares outstanding (28 Jul 2022) 47.77%
Shares short (prior month 29 Jun 2022) 43.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)-56,300.27%

Management effectiveness

Return on assets (ttm)-27.61%
Return on equity (ttm)-58.83%

Income statement

Revenue (ttm)366k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -200.99M
Net income avi to common (ttm)-205.3M
Diluted EPS (ttm)-5.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)513.2M
Total cash per share (mrq)12.03
Total debt (mrq)29.12M
Total debt/equity (mrq)7.76
Current ratio (mrq)14.57
Book value per share (mrq)8.80

Cash flow statement

Operating cash flow (ttm)3.35M
Levered free cash flow (ttm)-78.92M